FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1596429230> ?p ?o ?g. }

• W1596429230 endingPage "e0132669" @default.
• W1596429230 startingPage "e0132669" @default.
• W1596429230 abstract "Serological detection of Epstein-Barr virus (EBV) antibodies is frequently used in nasopharyngeal carcinoma (NPC) mass screening. However, the large number of seropositive subjects who require close follow-up is still a big burden. The present study aimed to detect the nasopharyngeal EBV load in a high-risk population seropositive for antibodies against EBV, as well as to examine whether assay for nasopharyngeal EBV DNA load might reduce the number of high-risk subjects for follow-up and improve early detection of NPC. A prospective and population-based cohort study was conducted in southern China from 2006 through 2013. Among 22,186 participants, 1045 subjects with serum immunoglobulin A (IgA) antibodies against viral capsid antigen (VCA) titers ≥ 1:5 were defined as high-risk group, and were then followed-up for NPC occurrence. Qualified nasopharyngeal swab specimens were available from 905 participants and used for quantitative PCR assay. Our study revealed that 89% (802/905) subjects showed positive EBV DNA in nasopharyngeal swab. The nasopharyngeal EBV load in females was higher than that in males. The nasopharyngeal EBV load increased with increasing serum VCA/IgA titers. Eight cases of newly diagnosed NPC showed an extremely elevated EBV load, and 87.5% (7 of 8 patients) were early-stage NPCs. The EBV loads of 8 NPCs were significantly higher than those of 897 NPC-free subjects (mean, 2.8 × 10(6) copies/swab [range 4.8 × 10(4)-1.1 × 10(8)] vs. 5.6 × 10(3) [range 0-3.8 × 10(6)]). Using mean EBV load in NPC-free population plus two standard deviations as cut-off value, a higher diagnostic performance was obtained for EBV load test than serum VCA/IgA test (area under ROC, 0.980 vs 0.895). In conclusion, in a prospective and population-based study we demonstrated that an additional assay of EBV load in the nasopharynx among high-risk individuals may reduce the number of subjects needed to be closely followed up and could serve as part of a NPC screening program in high-risk populations." @default.
• W1596429230 created "2016-06-24" @default.
• W1596429230 creator A5000923634 @default.
• W1596429230 creator A5009697908 @default.
• W1596429230 creator A5020078865 @default.
• W1596429230 creator A5031444341 @default.
• W1596429230 creator A5035433961 @default.
• W1596429230 creator A5041331651 @default.
• W1596429230 creator A5047932411 @default.
• W1596429230 creator A5052869072 @default.
• W1596429230 creator A5061947802 @default.
• W1596429230 creator A5067033171 @default.
• W1596429230 creator A5075666941 @default.
• W1596429230 creator A5089110764 @default.
• W1596429230 date "2015-07-07" @default.
• W1596429230 modified "2023-10-17" @default.
• W1596429230 title "Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening" @default.
• W1596429230 cites W1535128534 @default.
• W1596429230 cites W1627422266 @default.
• W1596429230 cites W1963527597 @default.
• W1596429230 cites W1968017437 @default.
• W1596429230 cites W1970555088 @default.
• W1596429230 cites W1994898506 @default.
• W1596429230 cites W2000234800 @default.
• W1596429230 cites W2001844373 @default.
• W1596429230 cites W2010608439 @default.
• W1596429230 cites W2017286592 @default.
• W1596429230 cites W2032720590 @default.
• W1596429230 cites W2039347950 @default.
• W1596429230 cites W2068009848 @default.
• W1596429230 cites W2070475645 @default.
• W1596429230 cites W2073151520 @default.
• W1596429230 cites W2073301179 @default.
• W1596429230 cites W2081610696 @default.
• W1596429230 cites W2084914593 @default.
• W1596429230 cites W2111247797 @default.
• W1596429230 cites W2111804619 @default.
• W1596429230 cites W2113496152 @default.
• W1596429230 cites W2115865929 @default.
• W1596429230 cites W2116038669 @default.
• W1596429230 cites W2127783072 @default.
• W1596429230 cites W2136080892 @default.
• W1596429230 cites W2146587137 @default.
• W1596429230 cites W2156267525 @default.
• W1596429230 cites W2342207742 @default.
• W1596429230 doi "https://doi.org/10.1371/journal.pone.0132669" @default.
• W1596429230 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4495031" @default.
• W1596429230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26151639" @default.
• W1596429230 hasPublicationYear "2015" @default.
• W1596429230 type Work @default.
• W1596429230 sameAs 1596429230 @default.
• W1596429230 citedByCount "32" @default.
• W1596429230 countsByYear W15964292302016 @default.
• W1596429230 countsByYear W15964292302017 @default.
• W1596429230 countsByYear W15964292302018 @default.
• W1596429230 countsByYear W15964292302019 @default.
• W1596429230 countsByYear W15964292302020 @default.
• W1596429230 countsByYear W15964292302021 @default.
• W1596429230 countsByYear W15964292302022 @default.
• W1596429230 countsByYear W15964292302023 @default.
• W1596429230 crossrefType "journal-article" @default.
• W1596429230 hasAuthorship W1596429230A5000923634 @default.
• W1596429230 hasAuthorship W1596429230A5009697908 @default.
• W1596429230 hasAuthorship W1596429230A5020078865 @default.
• W1596429230 hasAuthorship W1596429230A5031444341 @default.
• W1596429230 hasAuthorship W1596429230A5035433961 @default.
• W1596429230 hasAuthorship W1596429230A5041331651 @default.
• W1596429230 hasAuthorship W1596429230A5047932411 @default.
• W1596429230 hasAuthorship W1596429230A5052869072 @default.
• W1596429230 hasAuthorship W1596429230A5061947802 @default.
• W1596429230 hasAuthorship W1596429230A5067033171 @default.
• W1596429230 hasAuthorship W1596429230A5075666941 @default.
• W1596429230 hasAuthorship W1596429230A5089110764 @default.
• W1596429230 hasBestOaLocation W15964292301 @default.
• W1596429230 hasConcept C126322002 @default.
• W1596429230 hasConcept C142462285 @default.
• W1596429230 hasConcept C159047783 @default.
• W1596429230 hasConcept C159654299 @default.
• W1596429230 hasConcept C203014093 @default.
• W1596429230 hasConcept C22889606 @default.
• W1596429230 hasConcept C2522874641 @default.
• W1596429230 hasConcept C2778997737 @default.
• W1596429230 hasConcept C2781375147 @default.
• W1596429230 hasConcept C2908647359 @default.
• W1596429230 hasConcept C32611913 @default.
• W1596429230 hasConcept C45189115 @default.
• W1596429230 hasConcept C509974204 @default.
• W1596429230 hasConcept C71924100 @default.
• W1596429230 hasConcept C99454951 @default.
• W1596429230 hasConceptScore W1596429230C126322002 @default.
• W1596429230 hasConceptScore W1596429230C142462285 @default.
• W1596429230 hasConceptScore W1596429230C159047783 @default.
• W1596429230 hasConceptScore W1596429230C159654299 @default.
• W1596429230 hasConceptScore W1596429230C203014093 @default.
• W1596429230 hasConceptScore W1596429230C22889606 @default.
• W1596429230 hasConceptScore W1596429230C2522874641 @default.
• W1596429230 hasConceptScore W1596429230C2778997737 @default.
• W1596429230 hasConceptScore W1596429230C2781375147 @default.

• next